Financials PolarCool AB

Equities

POLAR

SE0012570422

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET 5-day change 1st Jan Change
- SEK -.--% Intraday chart for PolarCool AB -.--% -.--%

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - 0.264 0.6767 0.7463 1.904 1.373
EBITDA 1 -2.131 -6.494 -6.394 -6.548 -11.01 -10.57
EBIT 1 -2.202 -6.65 -6.823 -7.093 -12.19 -11.8
Operating Margin - -2,519.22% -1,008.35% -950.45% -640.53% -859.51%
Earnings before Tax (EBT) 1 -2.202 -6.65 -6.867 -7.103 -12.19 -12.11
Net income 1 -2.202 -6.65 -6.867 -7.103 -12.19 -12.11
Net margin - -2,519.47% -1,014.83% -951.72% -640.57% -881.62%
EPS 2 -2.771 -2.472 -1.655 -0.8262 -1.070 -0.4096
Free Cash Flow 1 -6.881 -4.346 -4.642 -6.853 -4.778 -4.403
FCF margin - -1,646.67% -685.98% -918.27% -251% -320.64%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 18/02/19 09/06/20 14/04/21 13/04/22 05/04/23 03/05/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 6.94 0.1 8.87 4.35 0.03 1.63
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -6.88 -4.35 -4.64 -6.85 -4.78 -4.4
ROE (net income / shareholders' equity) -34.3% -70.1% -64% -49.9% -127% -231%
ROA (Net income/ Total Assets) -15.3% -37.6% -31.1% -24.5% -53% -67.4%
Assets 1 14.37 17.71 22.1 28.95 23.01 17.97
Book Value Per Share 2 4.760 2.290 1.790 1.310 0.4900 0.0800
Cash Flow per Share 2 2.580 0.0400 1.040 0.4300 0.1200 0.0300
Capex 1 0.01 0.79 1.33 2.87 0.5 0.5
Capex / Sales - 298.2% 196.01% 385.06% 26.16% 36.27%
Announcement Date 18/02/19 09/06/20 14/04/21 13/04/22 05/04/23 03/05/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. POLAR Stock
  4. Financials PolarCool AB